Casting a broader net for approaches to antibacterial research and development

Current Opinion in Biotechnology

Volumn 19, Issue 6, 2008, Pages 606-607

  Payne, David ^a   Bush, Karen ^b  

^a GLAXOSMITHKLINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBODY; ANTIINFECTIVE AGENT; MONOBACTAM DERIVATIVE; NATURAL PRODUCT; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOXIN;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIOPHAGE; CLIMATE CHANGE; CLOSTRIDIUM DIFFICILE; CYSTIC FIBROSIS; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; SAFETY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG DESIGN;

EID: 57049095824     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2008.10.015     Document Type: Editorial

References (0)